Johnson & JohnsonJNJ

$228.39-5.81 (-2.48%)

NYSEHealthcareDividend King24:00 UTC

Company snapshot

Market Cap

$558B

Mega-cap

+68%

2016 — today

10-Year Price

+92%

2016 — today

52-Week Range

$151.32$248.56

Current $228.39· 79%

Johnson & Johnson (JNJ) researches, develops, and distributes healthcare products globally. Following the 2023 divestiture of its Consumer Health division (Kenvue), the company now focuses on two core segments: Innovative Medicine and MedTech. Innovative Medicine produces prescription drugs for complex conditions like cancer, HIV/AIDS, and neurodegenerative disorders. MedTech delivers surgical technologies, orthopaedic implants, and ACUVUE contact lenses. J&J has advanced human health since 1886.